Health Canada drug identification number

DIN 02327619 — ZOLINZA 100 MG

ZOLINZA is a capsule of Vorinostat marketed by MERCK CANADA INC. The full Vorinostat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02327619
Brand name
ZOLINZA
Active ingredient
Vorinostat
Strength
100 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
MERCK CANADA INC
Health Canada status
MARKETED
Drug class
Histone deacetylase (HDAC) inhibitor, antineoplastic agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.